These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [Hyperhomocysteinemia and cardiometabolic risk]. Vannucchi H; Melo SS Arq Bras Endocrinol Metabol; 2009 Jul; 53(5):540-9. PubMed ID: 19768245 [TBL] [Abstract][Full Text] [Related]
9. Impaired homocysteine metabolism and atherothrombotic disease. Durand P; Prost M; Loreau N; Lussier-Cacan S; Blache D Lab Invest; 2001 May; 81(5):645-72. PubMed ID: 11351038 [TBL] [Abstract][Full Text] [Related]
10. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases. Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M Z Kardiol; 2004 Jun; 93(6):439-53. PubMed ID: 15252738 [TBL] [Abstract][Full Text] [Related]
11. Effect of homocysteine-lowering treatment with folic acid plus vitamin B6 on progression of subclinical atherosclerosis: a randomised, placebo-controlled trial. Vermeulen EG; Stehouwer CD; Twisk JW; van den Berg M; de Jong SC; Mackaay AJ; van Campen CM; Visser FC; Jakobs CA; Bulterjis EJ; Rauwerda JA Lancet; 2000 Feb; 355(9203):517-22. PubMed ID: 10683000 [TBL] [Abstract][Full Text] [Related]
12. The association of homocysteine and coronary artery disease. Gauthier GM; Keevil JG; McBride PE Clin Cardiol; 2003 Dec; 26(12):563-8. PubMed ID: 14677809 [TBL] [Abstract][Full Text] [Related]
13. [Homocysteine--a risk factor for atherosclerosis]. Debreceni L Orv Hetil; 2001 Jul; 142(27):1439-44. PubMed ID: 11481906 [TBL] [Abstract][Full Text] [Related]
14. [Hyperhomocysteinemia in pediatric age and nutritional aspects of folates: an early cardiovascular risk factor]. Caramia G; Belardinelli R Monaldi Arch Chest Dis; 2006 Dec; 66(4):275-85. PubMed ID: 17312847 [TBL] [Abstract][Full Text] [Related]
15. DACH-LIGA homocystein (german, austrian and swiss homocysteine society): consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations. Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M; Clin Chem Lab Med; 2003 Nov; 41(11):1392-403. PubMed ID: 14656016 [TBL] [Abstract][Full Text] [Related]
16. Vitamin supplements and cardiovascular risk: review of the randomized trials of homocysteine-lowering vitamin supplements. Clarke R; Armitage J Semin Thromb Hemost; 2000; 26(3):341-8. PubMed ID: 11011852 [TBL] [Abstract][Full Text] [Related]
17. Analytic Approaches for the Treatment of Hyperhomocysteinemia and Its Impact on Vascular Disease. Kang SS; Rosenson RS Cardiovasc Drugs Ther; 2018 Apr; 32(2):233-240. PubMed ID: 29679304 [TBL] [Abstract][Full Text] [Related]